Market revenue in 2020 | USD 255.5 million |
Market revenue in 2028 | USD 743.0 million |
Growth rate | 14.3% (CAGR from 2020 to 2028) |
Largest segment | Oral |
Fastest growing segment | Injectable |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical, Injectable, Oral |
Key market players worldwide | Pfizer Inc, Sanofi SA, AbbVie Inc, Galderma Group AG Registered Shares, Eli Lilly and Co, Regeneron Pharmaceuticals Inc, Otsuka Holdings Co Ltd, Novartis AG ADR, Incyte Corp, LEO Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis drugs market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 37.89% in 2020. Horizon Databook has segmented the Spain atopic dermatitis drugs market based on topical, injectable, oral covering the revenue growth of each sub-segment from 2017 to 2028.
The most commonly used treatments for atopic dermatitis in this country are corticosteroids (~90%), cyclosporine, azathioprine, and methotrexate. However, use of novel biologics is as low as 5.8%. As per NCBI in 2019, the constant use of immunosuppressants in atopic dermatitis patients is increasing their susceptibility to other conditions, which is expected to restrain the market.
Spanish pharmaceutical company Almirall S.A.is evaluating the use of Lebrikizumab for treating severe and moderate atopic dermatitis. Phase 3 of the study started in October 2019. The company has exclusive development rights for the product.
Spain was affected severely by the COVID-19 pandemic, which led to lifestyle changes such as frequent hand-washing and increased use of alcohol-based sanitizers, further increasing the incidence of hand atopic dermatitis. This is expected to propel the country’s market.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain atopic dermatitis drugs market , including forecasts for subscribers. This country databook contains high-level insights into Spain atopic dermatitis drugs market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account